Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6575286 | 0.95 | CA12 (0.35) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL6756914 | 0.95 | CA12 (0.39) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL6447601 | 0.95 | CA12 (0.41) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL4977307 | 0.93 | CA12 (0.40) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL1629571 | 0.91 | CA1 (0.47) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL4981736 | 0.89 | CA12 (0.42) | CA1CA12CA9MMP1MMP2 | |
| SCHEMBL6449555 | 0.88 | DNM1 (0.39) | CA1CA12CA9ALDH1A1CES1 | |
| SCHEMBL6446465 | 0.88 | DNM1 (0.39) | CA1CA12CA9ALDH1A1CES1 | |
| SCHEMBL4978063 | 0.86 | CYP1A2 (0.37) | CA1CA12CA9ALDH1A1HDAC3 | |
| SCHEMBL6142622 | 0.85 | CA12 (0.45) | CA1CA12CA9MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717471-B2 | Hydrogel microcapsules | ISP INVESTMENTS LLC (US) | 2023-08-08 | — | — | US | disclosed |
| US-20130302392-A1 | HYDROGEL MICROCAPSULES | HERCULES LLC | 2013-11-14 | — | — | US | disclosed |
| EP-2646002-A2 | HYDROGEL MICROCAPSULES | Isp Investments Inc. (US) | 2013-10-09 | — | — | EP | disclosed |
| WO-2012075293-A2 | HYDROGEL MICROCAPSULES | ISP INVESTMENTS INC. (US) | 2012-06-07 | — | — | WO | disclosed |
| US-5478631-A | Ink receptive layer containing pigment and binder of amphoteric latex | KANZAKI PAPER MFG. CO., LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717471-B2 | Hydrogel microcapsules | MITF, DSG1, SHH | CA1 3646/4885CA12 4024/4885CA9 2499/4885 |
| US-20130302392-A1 | HYDROGEL MICROCAPSULES | MITF, DSG1, SHH | CA1 3646/4885CA12 4024/4885CA9 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.